The national COVID-19 vaccination campaign targeting the extremely vulnerable: the Florence Medical Oncology Unit experience in patients with cancer

Maria S. Pino,Simone Cheli,Marco Perna,Valentina Fabbroni, Clara Giordano,Francesca Martella, Fabio Lanini,Angela S. Ribecco,Silvia Scoccianti,Carlotta Bacci, Valentina Baldazzi, Ilaria Bertolini, Greta Di Leonardo, Chiara Fulignati, Raffaella Grifoni, Elena Molinara, Sheila Rangan,Renato Tassi, Federica Furlan,Gil Goldzweig

European Journal of Cancer(2022)

引用 3|浏览3
暂无评分
摘要
•COVID-19 vaccination is recommended in patients with cancer.•We observed a first dose-refusal rate of 4.5%.•No safety concerns have emerged in our cohort of patients.•After two-dose prime-boost vaccination 6 cases of COVID-19 infection were reported.
更多
查看译文
关键词
COVID-19,Vaccination,Safety
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要